IL159538A0 - 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors - Google Patents

8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors

Info

Publication number
IL159538A0
IL159538A0 IL15953802A IL15953802A IL159538A0 IL 159538 A0 IL159538 A0 IL 159538A0 IL 15953802 A IL15953802 A IL 15953802A IL 15953802 A IL15953802 A IL 15953802A IL 159538 A0 IL159538 A0 IL 159538A0
Authority
IL
Israel
Prior art keywords
alanyl
heterocyclic compounds
ligase inhibitors
alanine ligase
alanine
Prior art date
Application number
IL15953802A
Other languages
English (en)
Original Assignee
Pliva D D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D D filed Critical Pliva D D
Publication of IL159538A0 publication Critical patent/IL159538A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15953802A 2001-06-28 2002-06-28 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors IL159538A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30168501P 2001-06-28 2001-06-28
PCT/US2002/020567 WO2003001887A2 (fr) 2001-06-28 2002-06-28 Composes heterocycliques en 8/17 et leurs utilisations comme inhibiteurs de la ligase de la d-alanyle-d-alanine

Publications (1)

Publication Number Publication Date
IL159538A0 true IL159538A0 (en) 2004-06-01

Family

ID=23164426

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15953802A IL159538A0 (en) 2001-06-28 2002-06-28 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
IL15954002A IL159540A0 (en) 2001-06-28 2002-06-28 Heterocyclic compounds as selective bacterial dhfr inhibitors and the uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL15954002A IL159540A0 (en) 2001-06-28 2002-06-28 Heterocyclic compounds as selective bacterial dhfr inhibitors and the uses thereof

Country Status (16)

Country Link
US (3) US7345048B2 (fr)
EP (2) EP1411949A4 (fr)
CN (2) CN1543465A (fr)
BG (1) BG108548A (fr)
BR (1) BR0211310A (fr)
CA (2) CA2451800A1 (fr)
CZ (2) CZ200442A3 (fr)
EA (1) EA200400094A1 (fr)
EE (2) EE200400042A (fr)
HU (2) HUP0700040A2 (fr)
IL (2) IL159538A0 (fr)
MX (1) MXPA04000159A (fr)
PL (2) PL374589A1 (fr)
SK (1) SK302004A3 (fr)
WO (2) WO2003001887A2 (fr)
YU (2) YU102303A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217703D0 (en) * 2002-07-31 2002-09-11 Univ Liverpool Pharmaceutical composition
AU2005304040B2 (en) * 2004-11-09 2009-04-23 F. Hoffmann-La Roche Ag Aminoquinazolines compounds
AU2006271809B2 (en) * 2005-07-21 2010-03-18 F. Hoffmann-La Roche Ag Pyrido [2 , 3-D] pyrimidine-2 , 4-diamine compounds as PTP1B inhibitors
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
SI22338A (sl) * 2006-08-18 2008-02-29 Univerza V Ljubljani, Fakulteta Za Farmacijo Diazendikarboksamidi kot inhibitorji d-alanil-d-alanin ligaze
TW200831528A (en) 2006-11-30 2008-08-01 Astrazeneca Ab Compounds
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
MX2010008269A (es) * 2008-02-01 2011-02-21 Takeda Pharmaceutical Inhibidores de hsp90.
DE112010001212T5 (de) * 2009-03-20 2012-07-05 The Board Of Regents Of The University Of Texas System Verfahren, urn einem medizinischen Gerät antimikrobielle Aktivität zu verleihen
AU2009351623B2 (en) * 2009-08-31 2014-12-11 Dow Agrosciences Llc Pteridines and their use as agrochemicals
EP3722297A1 (fr) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Composés modulateurs de récepteurs de type toll
CN106316966A (zh) * 2015-06-15 2017-01-11 董运勤 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法
WO2018045150A1 (fr) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Dérivés de 4,6-diamino-pyrido [3,2-d] pyrimidine en tant que modulateurs du récepteur de type toll
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
EP3576790A4 (fr) 2017-02-01 2020-12-23 Yale University Traitement de la résistance aux diurétiques
PE20211196A1 (es) 2018-01-05 2021-07-01 Novo Nordisk As Metodos para tratar inflamacion mediada por il-6 sin inmunosupresion
WO2020160202A1 (fr) * 2019-02-01 2020-08-06 Fmc Corporation Pyridines et pyrimidines diamino-substituées à titre d'herbicides
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
US3134778A (en) * 1963-08-20 1964-05-26 Smith Kline French Lab 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
RO56210A2 (fr) 1970-12-28 1974-08-01
US4079056A (en) * 1975-03-31 1978-03-14 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making pteridine compounds
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3445298A1 (de) * 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
WO1992017478A1 (fr) 1991-04-08 1992-10-15 Duquesne University Of The Holy Ghost DERIVES DE 5-ALKYLE-6-[[AMINO]METHYLE] PYRIDO [2,3-d] PYRIMIDINE ET PROCEDES DE PREPARATION ET D'UTILISATION DE CES DERIVES
US5547954A (en) 1994-05-26 1996-08-20 Fmc Corporation 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
ES2207657T3 (es) * 1995-02-27 2004-06-01 F. Hoffmann-La Roche Ag Pirrolderivados de dioxopirrolo.
WO1999050264A1 (fr) * 1998-03-30 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Derives de quinazoline
JP2000239277A (ja) 1999-02-19 2000-09-05 Kyowa Hakko Kogyo Co Ltd イミダゾキナゾリン誘導体
GB0219893D0 (en) 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
SK302004A3 (sk) 2005-07-01
CA2451800A1 (fr) 2003-01-09
WO2003001887A3 (fr) 2003-08-21
US20030181470A1 (en) 2003-09-25
CN1547472A (zh) 2004-11-17
MXPA04000159A (es) 2005-01-07
PL374589A1 (en) 2005-10-31
WO2003001887A2 (fr) 2003-01-09
EP1432713A2 (fr) 2004-06-30
YU102303A (sh) 2006-08-17
BG108548A (bg) 2005-05-31
EP1411949A2 (fr) 2004-04-28
EE200400042A (et) 2004-10-15
EP1432713A4 (fr) 2005-05-11
HUP0700061A2 (en) 2007-05-02
WO2003002064A2 (fr) 2003-01-09
BR0211310A (pt) 2006-10-31
CA2451840A1 (fr) 2003-01-09
CZ200443A3 (cs) 2004-08-18
EE200400043A (et) 2004-10-15
HUP0700040A2 (en) 2007-05-29
US20080090847A1 (en) 2008-04-17
US7345048B2 (en) 2008-03-18
CZ200442A3 (cs) 2004-10-13
US20030176436A1 (en) 2003-09-18
PL374259A1 (en) 2005-10-03
EA200400094A1 (ru) 2005-08-25
IL159540A0 (en) 2004-06-01
YU102503A (sh) 2006-08-17
EP1411949A4 (fr) 2004-11-24
WO2003002064A3 (fr) 2003-10-23
CN1543465A (zh) 2004-11-03

Similar Documents

Publication Publication Date Title
IL159538A0 (en) 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
HK1068874A1 (en) Heterocyclic compounds and methods of use
HK1061854A1 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
IL157131A0 (en) Nitrogen containing heterocyclic derivatives and pharmaceutical compositions containing the same
HK1074176A1 (en) Quinoline derivatives as neuropeptide y antagonists
IL160693A0 (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
PL373301A1 (en) Phosphodiesterase 4 inhibitors
IL157109A0 (en) Quinazolines as mmp-13 inhibitors
AU2003291310A8 (en) Fused heterocyclic compounds and use thereof
HK1064360A1 (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
AU2002344567A1 (en) Heterocyclic amide compounds as apolipoprotein b inhibitors
PL369855A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
GB0123437D0 (en) Heterocyclic compounds
EP1392317A4 (fr) 1-benzazepines substituees et leurs derives
GB0113342D0 (en) Novel Heterocycles 1
PL369831A1 (en) Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
GB0113344D0 (en) Novel heterocycles 3
GB0021315D0 (en) Heterocyclic compounds and intermediates thereof
GB0113343D0 (en) Novel Heterocycles 2
GB0202187D0 (en) "Inhibitors"
AU2002357594A1 (en) Nitrogen-containing heterocyclic compounds and use thereof